Researchers explore the latest advances in Cryptosporidium research at Tufts University.
December 18, 2018
October 31, 2018
Dr. Wes Van Voorhis is conducting a Phase 2A, clinical trial on the safety, tolerability, pharmacokinetics and efficacy of clofazimine in Cryptosporidiosis.